Royalty Pharma

Royalty Pharma

Buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.

Launch date
Employees
Market cap
AUD19.2b
Enterprise valuation
AUD27.0b (Public information from Sep 2024)
New York City New York (HQ)
Authorizing premium user...